These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 17125917)
1. Oncogenic pathways of AML1-ETO in acute myeloid leukemia: multifaceted manipulation of marrow maturation. Elagib KE; Goldfarb AN Cancer Lett; 2007 Jun; 251(2):179-86. PubMed ID: 17125917 [TBL] [Abstract][Full Text] [Related]
2. [Advances on pathogenesis research of acute myeloid leukemia with t(8;21)-- review]. Zeng HM; Guo Y; Zhu XF Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1632-7. PubMed ID: 21176386 [TBL] [Abstract][Full Text] [Related]
3. The Hematopoietic Transcription Factors RUNX1 and ERG Prevent AML1-ETO Oncogene Overexpression and Onset of the Apoptosis Program in t(8;21) AMLs. Mandoli A; Singh AA; Prange KHM; Tijchon E; Oerlemans M; Dirks R; Ter Huurne M; Wierenga ATJ; Janssen-Megens EM; Berentsen K; Sharifi N; Kim B; Matarese F; Nguyen LN; Hubner NC; Rao NA; van den Akker E; Altucci L; Vellenga E; Stunnenberg HG; Martens JHA Cell Rep; 2016 Nov; 17(8):2087-2100. PubMed ID: 27851970 [TBL] [Abstract][Full Text] [Related]
4. An AML1-ETO/miR-29b-1 regulatory circuit modulates phenotypic properties of acute myeloid leukemia cells. Zaidi SK; Perez AW; White ES; Lian JB; Stein JL; Stein GS Oncotarget; 2017 Jun; 8(25):39994-40005. PubMed ID: 28611288 [TBL] [Abstract][Full Text] [Related]
5. Hematopoietic stem cell expansion and distinct myeloid developmental abnormalities in a murine model of the AML1-ETO translocation. de Guzman CG; Warren AJ; Zhang Z; Gartland L; Erickson P; Drabkin H; Hiebert SW; Klug CA Mol Cell Biol; 2002 Aug; 22(15):5506-17. PubMed ID: 12101243 [TBL] [Abstract][Full Text] [Related]
6. E protein silencing by the leukemogenic AML1-ETO fusion protein. Zhang J; Kalkum M; Yamamura S; Chait BT; Roeder RG Science; 2004 Aug; 305(5688):1286-9. PubMed ID: 15333839 [TBL] [Abstract][Full Text] [Related]
7. Definition of a small core transcriptional circuit regulated by AML1-ETO. Stengel KR; Ellis JD; Spielman CL; Bomber ML; Hiebert SW Mol Cell; 2021 Feb; 81(3):530-545.e5. PubMed ID: 33382982 [TBL] [Abstract][Full Text] [Related]
8. AML1-ETO targets and suppresses cathepsin G, a serine protease, which is able to degrade AML1-ETO in t(8;21) acute myeloid leukemia. Jin W; Wu K; Li YZ; Yang WT; Zou B; Zhang F; Zhang J; Wang KK Oncogene; 2013 Apr; 32(15):1978-87. PubMed ID: 22641217 [TBL] [Abstract][Full Text] [Related]
9. AML1-ETO rapidly induces acute myeloblastic leukemia in cooperation with the Wilms tumor gene, WT1. Nishida S; Hosen N; Shirakata T; Kanato K; Yanagihara M; Nakatsuka S; Hoshida Y; Nakazawa T; Harada Y; Tatsumi N; Tsuboi A; Kawakami M; Oka Y; Oji Y; Aozasa K; Kawase I; Sugiyama H Blood; 2006 Apr; 107(8):3303-12. PubMed ID: 16380455 [TBL] [Abstract][Full Text] [Related]
10. The ETO domain is necessary for the developmental abnormalities associated with AML1-ETO expression in the hematopoietic stem cell compartment in vivo. de Guzman CG; Johnson A; Klug CA Blood Cells Mol Dis; 2003; 30(2):201-6. PubMed ID: 12732184 [TBL] [Abstract][Full Text] [Related]
11. Upregulation of CD200R1 in lineage-negative leukemic cells is characteristic of AML1-ETO-positive leukemia in mice. Kagiyama Y; Kitaura J; Togami K; Uchida T; Inoue D; Matsukawa T; Izawa K; Kawabata KC; Komeno Y; Oki T; Nakahara F; Sato K; Aburatani H; Kitamura T Int J Hematol; 2012 Nov; 96(5):638-48. PubMed ID: 23097187 [TBL] [Abstract][Full Text] [Related]
13. A Drosophila model identifies calpains as modulators of the human leukemogenic fusion protein AML1-ETO. Osman D; Gobert V; Ponthan F; Heidenreich O; Haenlin M; Waltzer L Proc Natl Acad Sci U S A; 2009 Jul; 106(29):12043-8. PubMed ID: 19581587 [TBL] [Abstract][Full Text] [Related]
14. Multi-sites cleavage of leukemogenic AML1-ETO fusion protein by caspase-3 and its contribution to increased apoptotic sensitivity. Lu Y; Peng ZG; Yuan TT; Yin QQ; Xia L; Chen GQ Leukemia; 2008 Feb; 22(2):378-86. PubMed ID: 17989718 [TBL] [Abstract][Full Text] [Related]
15. Heterochromatic gene repression of the retinoic acid pathway in acute myeloid leukemia. Fazi F; Zardo G; Gelmetti V; Travaglini L; Ciolfi A; Di Croce L; Rosa A; Bozzoni I; Grignani F; Lo-Coco F; Pelicci PG; Nervi C Blood; 2007 May; 109(10):4432-40. PubMed ID: 17244680 [TBL] [Abstract][Full Text] [Related]
16. AML1-ETO interacts with Sp1 and antagonizes Sp1 transactivity through RUNT domain. Wei H; Liu X; Xiong X; Wang Y; Rao Q; Wang M; Wang J FEBS Lett; 2008 Jun; 582(15):2167-72. PubMed ID: 18519037 [TBL] [Abstract][Full Text] [Related]
17. KRAS (G12D) cooperates with AML1/ETO to initiate a mouse model mimicking human acute myeloid leukemia. Zhao S; Zhang Y; Sha K; Tang Q; Yang X; Yu C; Liu Z; Sun W; Cai L; Xu C; Cui S Cell Physiol Biochem; 2014; 33(1):78-87. PubMed ID: 24480914 [TBL] [Abstract][Full Text] [Related]
18. Inability of RUNX1/AML1 to breach AML1-ETO block of embryonic stem cell definitive hematopoiesis. Peterson LF; Lo MC; Okumura AJ; Zhang DE Blood Cells Mol Dis; 2007; 39(3):321-8. PubMed ID: 17692541 [TBL] [Abstract][Full Text] [Related]
19. The t(8;21) fusion protein, AML1 ETO, specifically represses the transcription of the p14(ARF) tumor suppressor in acute myeloid leukemia. Linggi B; Müller-Tidow C; van de Locht L; Hu M; Nip J; Serve H; Berdel WE; van der Reijden B; Quelle DE; Rowley JD; Cleveland J; Jansen JH; Pandolfi PP; Hiebert SW Nat Med; 2002 Jul; 8(7):743-50. PubMed ID: 12091906 [TBL] [Abstract][Full Text] [Related]
20. Effects of the leukemia-associated AML1-ETO protein on hematopoietic stem and progenitor cells. Nimer SD; Moore MA Oncogene; 2004 May; 23(24):4249-54. PubMed ID: 15156180 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]